Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunovant, Inc. - Common Stock
(NQ:
IMVT
)
16.42
+1.22 (+8.03%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunovant, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
These 2 Biotech Stocks Are Bucking a Down Market Tuesday
September 26, 2023
Stock index futures pointed to a lower open on Wall Street Tuesday morning.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 26, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
September 26, 2023
Pre-market stock movers are among the biggest topics worth checking out on Tuesday and we have the latest news for investors!
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
September 18, 2023
Via
Benzinga
Where Immunovant Stands With Analysts
September 18, 2023
Via
Benzinga
What 11 Analyst Ratings Have To Say About Immunovant
August 16, 2023
Via
Benzinga
9 Analysts Have This to Say About Immunovant
July 18, 2023
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Immunovant: Here's What You Need To Know
May 23, 2023
Via
Benzinga
If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now
August 25, 2023
Roivant stock has outperformed the broader market and the biotech sector this year, mirroring the rise in the fortunes of its founder Vivek Ramaswamy.
Via
Benzinga
Immunovant's FcRn Strategy Gains Momentum: Analysts View ADHERE Study as De-Risking Factor for CIDP Clinical Development
July 18, 2023
Monday, Argenx SE (NASDAQ: ARGX) reported topline results from the ADHERE study evaluating Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in adults with chronic inflammatory demyelinating...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
July 17, 2023
It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!
Via
InvestorPlace
Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 17, 2023
U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Immunovant Inc. (NASDAQ: IMVT) is a Stock Spotlight on 5/23
May 23, 2023
Via
Investor Brand Network
Analyst Expectations for Immunovant's Future
May 23, 2023
Via
Benzinga
Recap: Immunovant Q4 Earnings
May 22, 2023
Via
Benzinga
Analyst Expectations for Immunovant's Future
April 25, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 1, 2023
May 01, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023
April 25, 2023
Via
Benzinga
7 Analysts Have This to Say About Immunovant
March 30, 2023
Via
Benzinga
Immunovant Inc. (NASDAQ: IMVT) is a Stock Spotlight on 3/24
March 24, 2023
Via
Investor Brand Network
Analyst Boosts Immunovant Price Target After Updated Pipeline Realignment
March 20, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
March 31, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
March 30, 2023
Via
Benzinga
Analyst Expectations for Immunovant's Future
February 07, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Immunovant
November 08, 2022
Within the last quarter, Immunovant (NASDAQ:IMVT) has observed the following analyst ratings:
Via
Benzinga
Immunovant Could Potentially Be An M&A Target, Writes Analyst
February 15, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
February 15, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
February 13, 2023
Via
Benzinga
Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector
December 23, 2022
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
6 Analysts Have This to Say About Immunovant
November 08, 2022
Over the past 3 months, 6 analysts have published their opinion on Immunovant (NASDAQ:IMVT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.